A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy. - Hsu EJ; Cao X; Moon B; Bae J; Sun Z; Liu Z; Fu YX (Nature communications, 2021)